Therapeutic agent for spinal cord injuries
US8518880B2 · kind B2 · utility
1Cited by
2References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 27, 2009 |
| Grant date | Aug 27, 2013 |
| Priority date | — |
| Expiry date | Sep 5, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a therapeutic agent effective for the fundamental treatment of a spinal cord injury and a demyelinating disease. Specifically disclosed are a therapeutic agent for a spinal cord injury and a therapeutic agent for a demyelinating disease, each of which comprises an HGF protein as an active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.